ICHR insider plans sale of common shares
ICHR reports a planned sale of 12,346 common shares through Goldman Sachs & Co. LLC, with an aggregate market value of $1,023,113.02, expected on July 17, 2026 on the NASD market.
Rhea-AI Filing Summary
ICHR reports a planned sale of 12,346 common shares through Goldman Sachs & Co. LLC, with an aggregate market value of $1,023,113.02, expected on July 17, 2026 on the NASD market. The shares relate to equity compensation, including restricted stock units granted on several dates in 2022 and 2023. Over the previous three months, the Thomas M. Rohrs and Marion Rohrs Revocable Trust sold 10,000 common shares for $731,292 on May 15, 2026 and 8,000 common shares for $698,673.60 on June 12, 2026.
Positive
- None.
Negative
- None.
Key Figures
Key Terms
Restricted Stock Units financial
revocable trust financial
aggregate market value financial
NASD financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stock sale is being planned for ICHR in this Form 144 filing?
What restricted stock unit grants for ICHR are listed in the Form 144?
Who is identified as a selling security holder for ICHR in recent transactions?
AI-generated analysis. How Rhea-AI works. Not financial advice.